Sarepta Therapeutics, Inc. (SRPT)
USD 63.51
(1.16%)
USD 63.51
(1.16%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.39 Billion USD | -13.64% |
| 2022 | 1.61 Billion USD | 42.07% |
| 2021 | 1.13 Billion USD | 6.11% |
| 2020 | 1.07 Billion USD | 47.04% |
| 2019 | 729.62 Million USD | 73.49% |
| 2018 | 420.55 Million USD | -2.44% |
| 2017 | 431.05 Million USD | 2569.05% |
| 2016 | 16.15 Million USD | -30.98% |
| 2015 | 23.39 Million USD | 269.75% |
| 2014 | 6.32 Million USD | 279.38% |
| 2013 | 1.66 Million USD | -5.07% |
| 2012 | 1.75 Million USD | -4.61% |
| 2011 | 1.84 Million USD | -4.21% |
| 2010 | 1.92 Million USD | -3.9% |
| 2009 | 2 Million USD | -3.55% |
| 2008 | 2.07 Million USD | -3.13% |
| 2007 | 2.14 Million USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.37 Billion USD | -1.25% |
| 2024 Q2 | 1.36 Billion USD | -0.68% |
| 2023 Q2 | 1.36 Billion USD | 5.94% |
| 2023 FY | 1.39 Billion USD | -13.64% |
| 2023 Q4 | 1.39 Billion USD | 1.84% |
| 2023 Q1 | 1.28 Billion USD | -20.35% |
| 2023 Q3 | 1.37 Billion USD | 0.5% |
| 2022 Q1 | 1.13 Billion USD | -0.08% |
| 2022 Q2 | 1.14 Billion USD | 0.24% |
| 2022 Q3 | 1.57 Billion USD | 38.39% |
| 2022 Q4 | 1.61 Billion USD | 2.49% |
| 2022 FY | 1.61 Billion USD | 42.07% |
| 2021 Q1 | 1.15 Billion USD | 7.36% |
| 2021 FY | 1.13 Billion USD | 6.11% |
| 2021 Q2 | 1.15 Billion USD | 0.56% |
| 2021 Q3 | 1.15 Billion USD | 0.01% |
| 2021 Q4 | 1.13 Billion USD | -1.72% |
| 2020 Q3 | 768.69 Million USD | 0.28% |
| 2020 FY | 1.07 Billion USD | 47.04% |
| 2020 Q1 | 753.21 Million USD | 3.23% |
| 2020 Q2 | 766.55 Million USD | 1.77% |
| 2020 Q4 | 1.07 Billion USD | 39.57% |
| 2019 Q3 | 486.16 Million USD | 1.02% |
| 2019 Q2 | 481.24 Million USD | 0.7% |
| 2019 Q1 | 477.91 Million USD | 13.64% |
| 2019 Q4 | 729.62 Million USD | 50.08% |
| 2019 FY | 729.62 Million USD | 73.49% |
| 2018 Q4 | 420.55 Million USD | 1.23% |
| 2018 Q2 | 439.43 Million USD | 2.0% |
| 2018 FY | 420.55 Million USD | -2.44% |
| 2018 Q3 | 415.44 Million USD | -5.46% |
| 2018 Q1 | 430.81 Million USD | -0.06% |
| 2017 Q4 | 431.05 Million USD | 1277.95% |
| 2017 Q2 | 11.21 Million USD | -18.06% |
| 2017 Q3 | 31.28 Million USD | 178.88% |
| 2017 Q1 | 13.68 Million USD | -15.24% |
| 2017 FY | 431.05 Million USD | 2569.05% |
| 2016 Q4 | 16.15 Million USD | -13.16% |
| 2016 Q2 | 20.21 Million USD | -3.62% |
| 2016 Q3 | 18.59 Million USD | -8.01% |
| 2016 Q1 | 20.97 Million USD | -10.35% |
| 2016 FY | 16.15 Million USD | -30.98% |
| 2015 Q4 | 23.39 Million USD | 0.48% |
| 2015 Q3 | 23.28 Million USD | -9.25% |
| 2015 Q2 | 25.66 Million USD | 302.19% |
| 2015 Q1 | 6.38 Million USD | 0.82% |
| 2015 FY | 23.39 Million USD | 269.75% |
| 2014 Q2 | 1.62 Million USD | -1.46% |
| 2014 Q4 | 6.32 Million USD | 0.84% |
| 2014 FY | 6.32 Million USD | 279.38% |
| 2014 Q1 | 1.64 Million USD | -1.38% |
| 2014 Q3 | 6.27 Million USD | 287.11% |
| 2013 Q4 | 1.66 Million USD | -1.3% |
| 2013 FY | 1.66 Million USD | -5.07% |
| 2013 Q3 | 1.69 Million USD | -1.29% |
| 2013 Q2 | 1.71 Million USD | -1.33% |
| 2013 Q1 | 1.73 Million USD | -1.25% |
| 2012 FY | 1.75 Million USD | -4.61% |
| 2012 Q1 | 1.82 Million USD | -1.14% |
| 2012 Q3 | 1.77 Million USD | -1.22% |
| 2012 Q4 | 1.75 Million USD | -1.18% |
| 2012 Q2 | 1.8 Million USD | -1.15% |
| 2011 FY | 1.84 Million USD | -4.21% |
| 2011 Q2 | 1.88 Million USD | -1.05% |
| 2011 Q3 | 1.86 Million USD | -1.12% |
| 2011 Q4 | 1.84 Million USD | -1.07% |
| 2011 Q1 | 1.9 Million USD | -1.04% |
| 2010 Q3 | 1.94 Million USD | -0.97% |
| 2010 Q4 | 1.92 Million USD | -1.03% |
| 2010 FY | 1.92 Million USD | -3.9% |
| 2010 Q1 | 3.08 Million USD | 54.37% |
| 2010 Q2 | 1.96 Million USD | -36.48% |
| 2009 Q2 | 2.61 Million USD | 1.2% |
| 2009 FY | 2 Million USD | -3.55% |
| 2009 Q1 | 2.58 Million USD | 24.65% |
| 2009 Q4 | 2 Million USD | -1.23% |
| 2009 Q3 | 2.02 Million USD | -22.58% |
| 2008 Q4 | 2.07 Million USD | -0.68% |
| 2008 Q1 | 2.12 Million USD | -0.82% |
| 2008 FY | 2.07 Million USD | -3.13% |
| 2008 Q2 | 2.1 Million USD | -0.83% |
| 2008 Q3 | 2.08 Million USD | -0.85% |
| 2007 FY | 2.14 Million USD | 0.0% |
| 2007 Q4 | 2.14 Million USD | -0.8% |
| 2007 Q3 | 2.15 Million USD | -0.78% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | 2.17 Million USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -3565.778% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -48535.376% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -25506.013% |
| Autolus Therapeutics plc | 52.96 Million USD | -2537.129% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -135249.612% |
| Shattuck Labs, Inc. | 4.2 Million USD | -33141.504% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -385758.564% |
| CervoMed Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -5477.861% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -6588.338% |
| Aptose Biosciences Inc. | 1 Million USD | -138224.391% |
| Precision BioSciences, Inc. | 31.26 Million USD | -4367.212% |
| Dyadic International, Inc. | 136.92 Thousand USD | -1019996.546% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -1411.157% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -883955.696% |
| Nektar Therapeutics | 230.4 Million USD | -506.251% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -9895.764% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -652614.019% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -25440.464% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -533032.824% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -508.811% |
| GRI Bio, Inc. | 14 Thousand USD | -9977100.0% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -11142.82% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -983567.606% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -18141.29% |
| IGM Biosciences, Inc. | 40.5 Million USD | -3348.398% |
| INmune Bio, Inc. | 10.43 Million USD | -13283.233% |
| Opthea Limited | 200.62 Million USD | -596.215% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -2597.843% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -987.62% |
| Verastem, Inc. | 41.55 Million USD | -3261.186% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -25766.815% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -12182.87% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -14134.261% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -22557.064% |
| NextCure, Inc. | 6.6 Million USD | -21047.737% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -224466.119% |
| Organovo Holdings, Inc. | 1.39 Million USD | -100101.435% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Arvinas, Inc. | 3.4 Million USD | -40982.588% |
| Ovid Therapeutics Inc. | 46 Million USD | -2936.425% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -6476.618% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -4540.712% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -1551.308% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -4522.743% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -2150.194% |
| Senti Biosciences, Inc. | 37.66 Million USD | -3608.405% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -860443.258% |
| Apollomics, Inc. | 4.66 Million USD | -29867.99% |
| PureTech Health plc | 25.51 Million USD | -5375.102% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -439147.799% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -10664.551% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -1549.63% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 3.27 Million USD | -42524.596% |
| Beam Therapeutics Inc. | 173.17 Million USD | -706.597% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -1240.738% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -4462.645% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -1159.202% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -1233.15% |
| Mesoblast Limited | 118.92 Million USD | -1074.548% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -509.452% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -1249.104% |
| MediWound Ltd. | 6.71 Million USD | -20713.709% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -1277.74% |
| Fortress Biotech, Inc. | 88.59 Million USD | -1476.675% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -273.757% |
| Achilles Therapeutics plc | 4.61 Million USD | -30166.696% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -552.909% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -9119.246% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -2111.294% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -14753.339% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -4301.891% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -116.605% |
| FibroGen, Inc. | 170.45 Million USD | -719.459% |
| Celcuity Inc. | 37.44 Million USD | -3630.165% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -15281.654% |
| ContextLogic Inc. | 6 Million USD | -23180.133% |
| GH Research PLC | 343 Thousand USD | -407132.653% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -21196.051% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -3775056.757% |
| ImmuCell Corporation | 11.96 Million USD | -11569.919% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -32866.911% |
| Amarin Corporation plc | 8.73 Million USD | -15887.273% |
| TG Therapeutics, Inc. | 110.79 Million USD | -1160.714% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -25781.193% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -50036.683% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -2998.991% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -98336.082% |
| Aptorum Group Limited | 3.36 Million USD | -41442.031% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -3135.674% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | -64.58% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -356226.753% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -1112.812% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -309908.412% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -20126.006% |
| Ardelyx, Inc. | 55.98 Million USD | -2395.102% |
| Ainos, Inc. | 5.96 Million USD | -23322.401% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -5096.265% |
| Prothena Corporation plc | 11.83 Million USD | -11702.349% |
| HilleVax, Inc. | 51.19 Million USD | -2628.514% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -5435.201% |
| Celularity Inc. | 65.41 Million USD | -2035.237% |
| Rallybio Corporation | 392 Thousand USD | -356228.571% |
| Cue Biopharma, Inc. | 14.69 Million USD | -9405.328% |
| Omeros Corporation | 338.28 Million USD | -312.914% |
| Humacyte, Inc. | 58.1 Million USD | -2303.896% |
| Immunocore Holdings plc | 84.03 Million USD | -1562.233% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -75280.896% |
| Blueprint Medicines Corporation | 774.12 Million USD | -80.438% |
| IO Biotech, Inc. | 2.49 Million USD | -55906.736% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -2408189.655% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -27735.951% |
| Summit Therapeutics Inc. | 106.09 Million USD | -1216.514% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -1165.706% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -2159.549% |
| Pulmatrix, Inc. | 8.75 Million USD | -15852.581% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -20093.841% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -2296.678% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -9985.256% |
| Acelyrin, Inc. | 1.19 Million USD | -116885.595% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -1110.972% |
| Cytokinetics, Incorporated | 755.77 Million USD | -84.819% |
| Vor Biopharma Inc. | 35.66 Million USD | -3817.016% |
| Evogene Ltd. | 1.13 Million USD | -122642.355% |
| Replimune Group, Inc. | 75.86 Million USD | -1741.079% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -113832.137% |
| PDS Biotechnology Corporation | 23.85 Million USD | -5756.24% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -2531954.745% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 19.716% |
| AEON Biopharma, Inc. | 278 Thousand USD | -502348.921% |
| BioLineRx Ltd. | 11.59 Million USD | -11950.798% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -1845.225% |
| Atai Life Sciences N.V. | 16.47 Million USD | -8377.834% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -206834.519% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -65787.17% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -2951.598% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -2148835.385% |
| MediciNova, Inc. | 215.92 Thousand USD | -646791.991% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -55884.289% |
| MiMedx Group, Inc. | 48.09 Million USD | -2804.027% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -110667.406% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -649.473% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -236.559% |
| Mereo BioPharma Group plc | 5.95 Million USD | -23367.876% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -85331.682% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -15147.331% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -4995.05% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Allakos Inc. | 41.46 Million USD | -3268.643% |
| scPharmaceuticals Inc. | 40.26 Million USD | -3368.693% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -12808.308% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -924938.411% |
| NLS Pharmaceutics AG | 1.63 Million USD | -85397.256% |
| Precigen, Inc. | 7.09 Million USD | -19581.668% |
| XOMA Corporation | 124.45 Million USD | -1022.385% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -7277.637% |
| Incyte Corporation | 38.28 Million USD | -3548.257% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -464397.163% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -3135.824% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -12440.923% |
| Seer, Inc. | 28.25 Million USD | -4842.878% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -485.34% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -5263.468% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -400131.519% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -427721.73% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | -397.731% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -851783.611% |
| UroGen Pharma Ltd. | 100.21 Million USD | -1293.825% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -664.331% |
| Entera Bio Ltd. | 390 Thousand USD | -358055.897% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -457869.836% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -20336.108% |
| Chimerix, Inc. | 2.14 Million USD | -65049.627% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -143456.835% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -904.681% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -3828.554% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 75.903% |
| AnaptysBio, Inc. | 17.81 Million USD | -7741.069% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 47 Thousand USD | -2971831.915% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -57690.981% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -10413.383% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -107411.607% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -6542326.23% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -927678.737% |
| AbCellera Biologics Inc. | 77.38 Million USD | -1705.128% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -26602.504% |
| NLS Pharmaceutics AG | 1.63 Million USD | -85397.256% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 5.31 Million USD | -26164.948% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -247122.655% |
| Bicycle Therapeutics plc | 44.95 Million USD | -3007.056% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -1488.293% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -122319.632% |
| Erasca, Inc. | 55.85 Million USD | -2400.596% |
| bluebird bio, Inc. | 330.32 Million USD | -322.857% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | -23.189% |
| DBV Technologies S.A. | 14.38 Million USD | -9612.871% |
| Fortress Biotech, Inc. | 88.59 Million USD | -1476.675% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -14077.913% |
| CorMedix Inc. | 667.63 Thousand USD | -209118.252% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -245.075% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -22400.129% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -82698.34% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -30206.097% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -54849.174% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -12650.415% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -7308.943% |
| Onconetix, Inc. | 9.88 Million USD | -14029.478% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -10145.786% |
| Adagene Inc. | 22.3 Million USD | -6161.784% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -564.7% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -172686.312% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -128.622% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -1764.723% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -6783.201% |
| SciSparc Ltd. | 76 Thousand USD | -1837805.263% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -1603.075% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -424461.702% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -25099.495% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -85503.15% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -578.339% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 47.931% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -2217055.556% |
| 2seventy bio, Inc. | 256.67 Million USD | -444.197% |
| ADMA Biologics, Inc. | 141.41 Million USD | -887.716% |
| Clene Inc. | 32.16 Million USD | -4243.173% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -24788.982% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -63535.9% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -2656.568% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -290148.834% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -623.015% |
| Absci Corporation | 15.95 Million USD | -8653.575% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 48.322% |
| Surrozen, Inc. | 3.37 Million USD | -41237.911% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -4982.074% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -5591.5% |
| Cingulate Inc. | 3.13 Million USD | -44453.872% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -3406748.78% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -278757.982% |
| Jaguar Health, Inc. | 35.86 Million USD | -3795.17% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -231543.118% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -2341.759% |
| Kronos Bio, Inc. | 28.27 Million USD | -4840.606% |
| Innoviva, Inc. | 449.07 Million USD | -211.04% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -6808.393% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -1947.205% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -16136776.155% |
| Soligenix, Inc. | 3.49 Million USD | -39870.915% |
| AlloVir, Inc. | 27.42 Million USD | -4992.45% |
| Century Therapeutics, Inc. | 48.17 Million USD | -2799.687% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -13576.765% |
| Kura Oncology, Inc. | 17.2 Million USD | -8020.977% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -64867.814% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -3238.212% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -154073.068% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -677.612% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -23546.42% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -1709997.943% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -168832.471% |
| HCW Biologics Inc. | 6.45 Million USD | -21549.973% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -1868.0% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -2313.616% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -190.492% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -595627.403% |
| Histogen Inc. | 4.62 Million USD | -30120.857% |
| Surrozen, Inc. | 3.37 Million USD | -41237.911% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -364601.828% |
| Kodiak Sciences Inc. | 181.63 Million USD | -669.032% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -37673.354% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -668165.238% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -1761.517% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -35688.06% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 3.903% |
| Turnstone Biologics Corp. | 3.21 Million USD | -43360.112% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -565409.312% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -1331.053% |
| Exelixis, Inc. | 189.94 Million USD | -635.379% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -2933.967% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -4248.988% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -141707.919% |
| Alkermes plc | 290.73 Million USD | -380.449% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -50036.683% |
| Arcellx, Inc. | 97.62 Million USD | -1330.789% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -1738780.59% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -2858111.582% |
| Avid Bioservices, Inc. | 207.83 Million USD | -572.079% |
| Insmed Incorporated | 1.2 Billion USD | -16.015% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -64898.046% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -5168.389% |
| Moolec Science SA | 2.64 Million USD | -52703.607% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -4803.317% |
| Geron Corporation | 85.89 Million USD | -1526.105% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -22025.899% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -2969.233% |
| Royalty Pharma plc | 6.13 Billion USD | 77.233% |
| OmniAb, Inc. | 25.56 Million USD | -5364.606% |
| Alector, Inc. | 38.91 Million USD | -3489.105% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -58051.873% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -4028.903% |
| Humacyte, Inc. | 58.1 Million USD | -2303.896% |
| Structure Therapeutics Inc. | 5.45 Million USD | -25515.4% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -191.954% |
| 89bio, Inc. | 27.1 Million USD | -5052.752% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 19.55 Million USD | -7042.241% |
| Immunic, Inc. | 1.33 Million USD | -104608.246% |
| Veracyte, Inc. | 12.63 Million USD | -10959.446% |
| Genelux Corporation | 2.51 Million USD | -55350.893% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -104295.217% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -684908.656% |
| Immunovant, Inc. | 138 Thousand USD | -1012079.71% |
| Vericel Corporation | 88.14 Million USD | -1484.707% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 16.758% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -18989.9% |
| XBiotech Inc. | - USD | -Infinity% |
| Agenus Inc. | 350.24 Million USD | -298.808% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -1306659.222% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -1709997.943% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -2987.824% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -2796.199% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -687982.759% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -135855.881% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -6660.602% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -84401.391% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -110757.778% |
| United Therapeutics Corporation | 700 Million USD | -99.544% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -9840734.155% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -1382878.218% |
| Pharming Group N.V. | 171.54 Million USD | -714.252% |
| XOMA Corporation | 124.45 Million USD | -1022.385% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -482.931% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -10421.302% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -6448.254% |
| uniQure N.V. | 138.4 Million USD | -909.189% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -12091.743% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -808832.491% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -8199.513% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -1535.166% |
| Pluri Inc. | 29.61 Million USD | -4617.034% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 89.26 Million USD | -1464.806% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -28540.722% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -1241.846% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -213.848% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -482151.599% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -10421.302% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -4327.564% |
| Nutriband Inc. | 241.28 Thousand USD | -578803.786% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -25449.808% |
| Compugen Ltd. | 1.35 Million USD | -103290.674% |
| Roivant Sciences Ltd. | 499.74 Million USD | -179.502% |
| ProKidney Corp. | 4.41 Million USD | -31552.119% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -663501.423% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -3488.921% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -56889.403% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -3166.165% |
| Benitec Biopharma Inc. | 284 Thousand USD | -491733.803% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Biomea Fusion, Inc. | 10.29 Million USD | -13466.511% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -38808.301% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -9420.878% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -11295.073% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -1551.952% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -11069.103% |
| Imunon, Inc. | 1.62 Million USD | -85872.547% |
| BioAtla, Inc. | 2.46 Million USD | -56680.813% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -1368.454% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -25085.864% |
| Zura Bio Limited | - USD | -Infinity% |
| aTyr Pharma, Inc. | 15.09 Million USD | -9153.448% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -1091.887% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -6536.298% |
| Galecto, Inc. | 249 Thousand USD | -560867.068% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -85503.15% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 6.833% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -1216.948% |
| PolyPid Ltd. | 11.77 Million USD | -11758.46% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -1427.267% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 83.43 Million USD | -1574.147% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -113997.234% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -851783.611% |
| Instil Bio, Inc. | 86.05 Million USD | -1523.176% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -110667.406% |
| OncoCyte Corporation | 2.86 Million USD | -48586.232% |
| Elevation Oncology, Inc. | 30.13 Million USD | -4534.861% |
| Purple Biotech Ltd. | 351 Thousand USD | -397850.997% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -44116.777% |
| MacroGenics, Inc. | 33.97 Million USD | -4011.766% |
| Verona Pharma plc | 51.32 Million USD | -2621.284% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -68572.993% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -14185.212% |
| Aditxt, Inc. | 18.21 Million USD | -7567.192% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -5124.056% |
| Curis, Inc. | 2.79 Million USD | -49893.128% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -65279.89% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -8248.622% |
| BeiGene, Ltd. | 930.18 Million USD | -50.165% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -55727.658% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -33308.467% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -29977.692% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -2205.763% |
| Adicet Bio, Inc. | 20.92 Million USD | -6575.626% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -9027.674% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | -1326.858% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -5421.417% |
| Invivyd, Inc. | 2.16 Million USD | -64417.691% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -2512.516% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -39639940.525% |
| Moolec Science SA | 2.64 Million USD | -52703.607% |
| Clearside Biomedical, Inc. | 43 Million USD | -3148.315% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -293964.842% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -8022.393% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -1021.574% |
| Evaxion Biotech A/S | 10.86 Million USD | -12750.499% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -1575.051% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -21402.586% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -5075.28% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -300288.817% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -19786.219% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -39169.272% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -89726.881% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -110757.778% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -9570.507% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -2600.294% |
| ImmunityBio, Inc. | 883.67 Million USD | -58.068% |
| Korro Bio, Inc. | 33.2 Million USD | -4106.366% |
| Kineta, Inc. | 1.31 Million USD | -105959.833% |
| BioVie Inc. | 6.11 Million USD | -22755.602% |
| Codexis, Inc. | 22.36 Million USD | -6145.788% |
| Celularity Inc. | 65.41 Million USD | -2035.237% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -622640.972% |
| Cibus, Inc. | 24.62 Million USD | -5573.238% |
| Annexon, Inc. | 31.35 Million USD | -4354.817% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -59541.674% |
| Eyenovia, Inc. | 16.1 Million USD | -8571.647% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -1152.855% |
| NeurAxis, Inc. | 224.26 Thousand USD | -622752.047% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -44929.271% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -80500.577% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -1211838.848% |
| Notable Labs, Ltd. | 2.04 Million USD | -68070.229% |
| IN8bio, Inc. | 4.89 Million USD | -28447.067% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -349102.0% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -2500.745% |
| Lumos Pharma, Inc. | 6.58 Million USD | -21111.967% |
| Liquidia Corporation | 3.5 Million USD | -39774.622% |
| Mustang Bio, Inc. | 2.49 Million USD | -55817.054% |
| Quantum-Si incorporated | 15.3 Million USD | -9027.674% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -15916.604% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -14185.212% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -509683.942% |
| 180 Life Sciences Corp. | 1.32 Million USD | -105713.257% |
| Vaxcyte, Inc. | 29.22 Million USD | -4679.661% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -12711.226% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -6911.736% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -8077.974% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -89726.881% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -346502.481% |
| PepGen Inc. | 20.1 Million USD | -6847.911% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -243246.341% |
| Solid Biosciences Inc. | 26.26 Million USD | -5218.134% |
| Palisade Bio, Inc. | 369 Thousand USD | -378438.753% |
| Nutriband Inc. | 241.28 Thousand USD | -578803.786% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -141707.919% |
| Immuneering Corporation | 4.46 Million USD | -31197.8% |
| Belite Bio, Inc | 886 Thousand USD | -157553.273% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -169005.085% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -336480.241% |
| Altimmune, Inc. | 671 Thousand USD | -208068.107% |
| Peak Bio, Inc. | 10.72 Million USD | -12927.729% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -15281.654% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -79854.665% |
| Neurogene Inc. | 16.25 Million USD | -8493.098% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -353.3% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -4794.04% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| argenx SE | 20 Million USD | -6884.04% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -6911.736% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -238670.598% |
| Immunome, Inc. | 1.65 Million USD | -84555.03% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 3.05 Million USD | -45696.984% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -9717.318% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -416857.612% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -1741.249% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -2185.84% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -4523.777% |
| Athira Pharma, Inc. | 1.58 Million USD | -88026.688% |
| XOMA Corporation | 124.45 Million USD | -1022.385% |
| Merus N.V. | 12.16 Million USD | -11385.019% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -10011.539% |
| Rezolute, Inc. | 2.22 Million USD | -62593.357% |
| Clene Inc. | 32.16 Million USD | -4243.173% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -797834.34% |
| BeyondSpring Inc. | 3.99 Million USD | -34863.905% |
| Synlogic, Inc. | 17.27 Million USD | -7985.719% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -107346.769% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -3990780.0% |
| Peak Bio, Inc. | 10.72 Million USD | -12927.729% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -2590.153% |
| Krystal Biotech, Inc. | 8.09 Million USD | -17157.329% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -689.086% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -19693.227% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -1022498.357% |
| MannKind Corporation | 382.37 Million USD | -265.294% |
| Ikena Oncology, Inc. | 10.73 Million USD | -12908.083% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -341417.848% |
| Gossamer Bio, Inc. | 212.46 Million USD | -557.433% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -802663.218% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -15147.331% |
| Legend Biotech Corporation | 328.67 Million USD | -324.985% |
| Mural Oncology plc | 15 Million USD | -9206.469% |
| Disc Medicine, Inc. | 2.1 Million USD | -66383.008% |
| Champions Oncology, Inc. | 7.43 Million USD | -18699.569% |
| REGENXBIO Inc. | 89.29 Million USD | -1464.35% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -163327.273% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -252495.564% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -25699.926% |
| Vaxart, Inc. | 26.51 Million USD | -5168.19% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -8821.095% |
| Cellectis S.A. | 92.85 Million USD | -1404.322% |
| Longeveron Inc. | 2.04 Million USD | -68337.433% |
| Repare Therapeutics Inc. | 3.41 Million USD | -40862.111% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -2897.957% |
| Revolution Medicines, Inc. | 87.94 Million USD | -1488.293% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -807303.468% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -35235.391% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -440533.438% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -798076.0% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | -72.787% |
| Denali Therapeutics Inc. | 52.24 Million USD | -2573.777% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -9596.377% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -101559.971% |
| Cingulate Inc. | 3.13 Million USD | -44453.872% |
| Passage Bio, Inc. | 26.29 Million USD | -5212.269% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -20857.359% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -342254.902% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -156142.506% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -6693.483% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -56886.497% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -44626.481% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -172132.799% |
| OmniAb, Inc. | 25.56 Million USD | -5364.606% |
| Anew Medical, Inc. | 1.6 Million USD | -86928.536% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -4621.679% |
| Lipocine Inc. | 17.16 Thousand USD | -8136961.633% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -11902.131% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -3933.753% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -23546.42% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -2343.125% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -687982.759% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -26943.717% |
| Ocugen, Inc. | 6.94 Million USD | -20024.017% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -9786.107% |
| Q32 Bio Inc. | 1.31 Million USD | -105879.363% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -207758.333% |
| Alumis Inc. Common Stock | 32.58 Million USD | -4187.317% |
| Equillium, Inc. | 824 Thousand USD | -169415.534% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -15285.042% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -464255.099% |
| Dominari Holdings Inc. | 3.02 Million USD | -46029.723% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -1478207.069% |
| vTv Therapeutics Inc. | 529 Thousand USD | -263946.881% |
| Bio-Techne Corporation | 419.53 Million USD | -232.94% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -1840.119% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -621.618% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -8171.009% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -6036.579% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -22957.247% |
| Nkarta, Inc. | 88.33 Million USD | -1481.191% |
| BioCardia, Inc. | 1.31 Million USD | -106121.141% |
| Iterum Therapeutics plc | 19.5 Million USD | -7059.813% |